4-Octyl itaconate attenuates cerebral ischemia reperfusion injury by mitigating mitochondrial dysfunction mediated neuronal apoptosis and ferroptosis via the Nrf2/HO-1/SLC7A11/GPX-4 axis
Mitochondrion · 2026
DOI: 10.1016/j.mito.2026.102204 ↗Kurz gefasst
Fachartikel in der Zeitschrift Mitochondrion, 2026. Verfasst von Chandan Chauhan und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology and Toxicology, National Institute of Pharmaceutical Education and Research, Raebareli (NIPER-R), Transit Campus, Bijnor-S…. Hauptthemen laut MEDLINE: Apoptosis, Reperfusion Injury, Ferroptosis, Neurons. Die Arbeit nennt 39 Literaturangaben.
Abstract (Originalsprache)
Ischemic stroke is an unmet therapeutic need, characterised by excessive oxidative stress, mitochondrial impairment, blood-brain barrier (BBB) damage, and neuronal cell death. 4-Octyl itaconate (4-OI) is known for its promising antioxidant properties; however, its effects in cerebral ischemia/reperfusion (I/R) injury have not been previously explored. In this study, middle cerebral artery occlusion/reperfusion (MCAO/R) and oxygen-glucose deprivation/reoxygenation (OGD/R) models were used to mimic the cerebral I/R injury. Treatment with 4-OI significantly improved neuronal survival and neurological outcomes, reduced oxidative damage and mitochondrial dysfunction. Mechanistically, 4-OI markedly attenuated intracellular and mitochondrial ROS, restored mitochondrial membrane potential, and inhibited neuronal apoptosis. Furthermore, 4-OI treatment exerts its neuroprotective effect by suppressing lipid peroxidation and modulating the Nrf2/HO-1/SLC7A11/GPX4 axis to inhibit ferroptosis and BBB damage. Pharmacological inhibition of Nrf2 using ML-385 abolished the effects of 4-OI, confirming the essential role of Nrf2 activation in mediating ferroptosis suppression. Additionally, molecular docking analysis revealed favourable binding of 4-OI to Keap-1, supporting a potential mechanism by which 4-OI impede the Keap1-Nrf2 interaction to promote Nrf2 activation. Collectively, these findings suggest that 4-OI confers neuroprotection against I/R injury by activating Nrf2 pathway, reducing oxidative stress, and suppressing ferroptotic and apoptotic cell death. This study identifies 4-OI as a promising therapeutic candidate for cerebral I/R injury and highlights the Nrf2-mediated ferroptosis pathway as a potential target for neuroprotection.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology and Toxicology, National Institute of Pharmaceutical Education and Research, Raebareli (NIPER-R), Transit Campus, Bijnor-Sisendi Road, Sarojini Nagar, Near CRPF Base Camp, Lucknow, UP- 226002,…
Zitieren
APA
Chauhan, C., & Kaundal, R. K. (2026). 4-Octyl itaconate attenuates cerebral ischemia reperfusion injury by mitigating mitochondrial dysfunction mediated neuronal apoptosis and ferroptosis via the Nrf2/HO-1/SLC7A11/GPX-4 axis. Mitochondrion. https://doi.org/10.1016/j.mito.2026.102204
Vancouver
Chauhan C, Kaundal RK. 4-Octyl itaconate attenuates cerebral ischemia reperfusion injury by mitigating mitochondrial dysfunction mediated neuronal apoptosis and ferroptosis via the Nrf2/HO-1/SLC7A11/GPX-4 axis. Mitochondrion. 2026. doi:10.1016/j.mito.2026.102204
BibTeX
@article{Chauhan2026,
author = {Chauhan, Chandan and Kaundal, Ravinder K},
title = {4-Octyl itaconate attenuates cerebral ischemia reperfusion injury by mitigating mitochondrial dysfunction mediated neuronal apoptosis and ferroptosis via the Nrf2/HO-1/SLC7A11/GPX-4 axis},
journal = {Mitochondrion},
year = {2026},
doi = {10.1016/j.mito.2026.102204}
}
EUVIMED